AstraZeneca’s Farxiga Letters Expand Dispensing and Billing Review
Manufacturer letters reviewing Farxiga dispensing and billing are raising documentation, NDC, purchase-history, and response-strategy questions for pharmacies.
May 10, 2026 / 6 min read